When testing new treatments, drugmakers must show that their formulation bears out better results than a placebo in clinical trials. In fact, the new drug must outperform the placebo by a statistically significant margin using a measurement called “p-value.”
In this short video, STAT national biotech reporter Damian Garde explains what p-value is, how it is used, and why it is still considered the gold standard for statistical significance, despite its shortcomings.
Create a display name to comment
This name will appear with your comment